Evidence map›Paper›PMID 33482358›Full record

ArticleClinical immunology (Orlando, Fla.)2021

Autoimmune experimental orchitis and chronic glomerulonephritis with end stage renal disease are controlled by Cgnz1 for susceptibility to end organ damage.

Zhenhuan Zhao, Hui Qiao, Y Ge, C C Kannapel, Sun-Sang J Sung, Felicia Gaskin, Kenneth S K Tung, Shu Man Fu

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Zhenhuan ZhaoDivision of Rheumatology, Center for Immunity, Inflammation and Regenerative Medicine, Charlottesville, VA, USA; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA.
Hui QiaoDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA; Department of Pathology, University of Virginia, Charlottesville, VA, USA.
Y GeDivision of Rheumatology, Center for Immunity, Inflammation and Regenerative Medicine, Charlottesville, VA, USA; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA.
C C KannapelDivision of Rheumatology, Center for Immunity, Inflammation and Regenerative Medicine, Charlottesville, VA, USA; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA.
Sun-Sang J SungDivision of Rheumatology, Center for Immunity, Inflammation and Regenerative Medicine, Charlottesville, VA, USA.
Felicia GaskinDepartment of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, USA.
Kenneth S K TungDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA; Department of Pathology, University of Virginia, Charlottesville, VA, USA; Bernie B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, USA. Electronic address: kst7k@virginia.edu.
Shu Man FuDivision of Rheumatology, Center for Immunity, Inflammation and Regenerative Medicine, Charlottesville, VA, USA; Department of Medicine, University of Virginia, Charlottesville, VA, USA; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA. Electronic address: sf2e@virginia.edu.
University of Virginia · USCenter for Neuroscience and Regenerative Medicine · USCarter Center · US

Funding

Cellular and Genetic Basis of Systemic LupusR01AR047988 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FU, SHU MAN · 2001 to 2020
$8.4M
Infections, Microbiome and HLA-DR in the Induction of Lupus Related Auto-antibodiesR01AI139673 · NIAID · UNIVERSITY OF VIRGINIA · PI SUNG, SUN-SANG JOSEPH · 2018 to 2022
$2.8M
NLRP3 Inflammasome Activation, T Follicular Helper Cells and AutoimmunityR01AI148231 · NIAID · UNIVERSITY OF VIRGINIA · PI SUNG, SUN-SANG JOSEPH · 2020 to 2023
$2.5M
NIAID NIH HHS R01 AI139673NIAID NIH HHS R01 AI148231NIAMS NIH HHS R01 AR047988
6 · The paper itself

Abstract

Cgnz1 on chromosome 1 mapped into a 1.34 Mb region of chromosome 1 in NZM2328 confers the progression of immune complex (IC)-mediated glomerulonephritis (GN) from acute GN (aGN) to chronic GN (cGN) with severe proteinuria and end stage renal disease in female mice. This genetic locus mediates podocyte susceptibility to IC-mediated damage. Taking advantage of the published observation that Cgnz1 is derived from NZW and that NZW is susceptible to orchitis, epididymitis and vasitis while C57L/J is resistant to these diseases, the possibility that this genetic region also confers germ cells susceptible to damage with aspermatogenesis and sterility in an active experimental autoimmune orchitis (EAO) model was investigated. Male mice from multiple intrachromosome (chromosome 1) recombinant strains were subjected to immunization with a sperm homogenate in CFA with concomitant administration of Bordetella pertussis toxin. There was concordance of the progression from aGN to cGN, severe proteinuria and end stage renal disease with susceptibility of EAO in NZM2328 and its congenic strains with various chromosome 1 genetic intervals introgressed from C57L/J to NZM2328. Both resistant and susceptible strains made comparable anti-testis and anti-sperm Abs. Thus the genetic interval that determines susceptibility to EAO is identical to that of Cgnz1 and mapped to the 1.34 Mb region in chromosone 1. This region likely confers germ cells in the male gonad susceptible to damage by immunologically mediated inflammation. This region has been tentatively renamed Cgnz1/Eaoz1. These observations further emphasize the importance of end organ susceptibility to damage in the pathogenesis of both systemic and organ specific autoimmune diseases.

Indexed as

Genetic Predisposition to DiseaseAnimalsAutoimmune DiseasesFemaleGene Expression RegulationGlomerulonephritisKidney Failure, ChronicMaleMiceOrchitisEnd organ damageExperimental autoimmune orchitisGlomerulonephritisMouse models of autoimmunitySusceptibility genesSystemic lupus erythematosus

Identifiers

PMID33482358
PMCPMC9297735
OpenAlexW3123256289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.